DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,450,144 | +2.9% | 5,845 | -0.4% | 0.22% | +4.8% |
| Q2 2023 | $1,408,800 | -7.9% | 5,870 | -3.3% | 0.21% | -12.1% |
| Q1 2023 | $1,529,883 | -5.4% | 6,070 | -0.3% | 0.24% | -7.7% |
| Q4 2022 | $1,616,408 | +3.5% | 6,090 | -3.8% | 0.26% | -7.2% |
| Q3 2022 | $1,561,000 | -3.9% | 6,329 | -1.2% | 0.28% | -0.7% |
| Q2 2022 | $1,624,000 | -13.8% | 6,407 | -0.3% | 0.28% | -4.1% |
| Q1 2022 | $1,884,000 | -10.9% | 6,424 | -0.0% | 0.29% | -11.2% |
| Q4 2021 | $2,115,000 | +8.7% | 6,427 | +0.6% | 0.33% | -0.9% |
| Q3 2021 | $1,945,000 | +6.7% | 6,390 | -5.9% | 0.33% | +6.7% |
| Q2 2021 | $1,823,000 | +18.7% | 6,793 | -0.4% | 0.31% | +8.3% |
| Q1 2021 | $1,536,000 | -4.2% | 6,823 | -5.5% | 0.29% | -11.4% |
| Q4 2020 | $1,604,000 | +3.3% | 7,219 | +0.1% | 0.32% | -11.0% |
| Q3 2020 | $1,553,000 | +26.2% | 7,214 | +3.6% | 0.36% | +7.4% |
| Q2 2020 | $1,231,000 | +137.6% | 6,964 | +86.3% | 0.34% | +89.9% |
| Q1 2020 | $518,000 | +10.0% | 3,739 | +21.9% | 0.18% | +23.4% |
| Q4 2019 | $471,000 | +6.3% | 3,067 | 0.0% | 0.14% | -2.7% |
| Q3 2019 | $443,000 | +2.1% | 3,067 | -1.0% | 0.15% | -2.6% |
| Q2 2019 | $434,000 | +6.1% | 3,097 | 0.0% | 0.15% | +1.3% |
| Q1 2019 | $409,000 | +13.6% | 3,097 | -11.2% | 0.15% | -1.3% |
| Q4 2018 | $360,000 | -10.2% | 3,488 | -5.4% | 0.15% | -4.4% |
| Q3 2018 | $401,000 | +13.0% | 3,688 | +2.6% | 0.16% | -30.1% |
| Q2 2018 | $355,000 | -2.5% | 3,595 | -3.2% | 0.23% | -37.8% |
| Q1 2018 | $364,000 | -99.8% | 3,714 | +66.6% | 0.37% | +76.9% |
| Q4 2017 | $206,896,000 | – | 2,229 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |